Clinic
Instituto De Hematologia Y Oncologia Medico Del Norte P.S.C.
Instituto De Hematologia Y Oncologia Medico Del Norte P.S.C. was paid $1.59M by Medicaid between Jan 2018 and Aug 2024, across 22 billing codes. Its largest line is Q0084, Chemotherapy administration by infusion technique only, per visit — 25% of everything it billed.
33Billing provider infoINSTITUTO DE HEMATOLOGIA Y ONCOLOGIA MEDICO DEL NORTE P.S.C.
MANATI, PR 00674
MANATI, PR 00674
33aNPI1033251780assigned 02/12/2007
33bProvider typeOncology Clinic/Center
28Total paid$1.59M
24GClaims39,388
24DCodes billed22
24AFirst – last monthJan 2018 – Aug 2024
Compared with peers
Next to other Oncology Clinic/Center providers in Puerto Rico
Rank by total paid#3 of 21
Median peer was paid$255K
This provider vs. median6.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,992 | $367K | |
| 2019 | 7,212 | $238K | |
| 2020 | 6,714 | $297K | |
| 2021 | 7,277 | $282K | |
| 2022 | 3,179 | $102K | |
| 2023 | 2,730 | $149K | |
| 2024incomplete | 2,284 | $153K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| Q0084 | Chemotherapy administration by infusion technique only, per visit | 25% | 5,497 | 3,075 | $392K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 24% | 8,633 | 6,224 | $377K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 13% | 3,547 | 1,906 | $209K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 11% | 3,949 | 3,206 | $167K |
| 96415 | 8.0% | 2,082 | 1,103 | $127K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7.0% | 1,731 | 1,419 | $111K |
| 99205 | Prolong outpt/office vis | 3.2% | 641 | 606 | $51K |
| 96367 | 2.8% | 1,624 | 953 | $44K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 2.3% | 2,589 | 1,443 | $36K |
| 96417 | 1.4% | 678 | 399 | $23K | |
| J1442 | Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram | 1.4% | 120 | 25 | $22K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 208 | 188 | $14K |
10 more codes
| 99221 | <1% | 60 | $5K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 28 | $3K |
| 96401 | <1% | 69 | $2K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 43 | $2K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,361 | $1K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 36 | $829.78 |
| J2780 | Injection, ranitidine hydrochloride, 25 mg | <1% | 399 | $705.83 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 3,139 | $449.59 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 38 | $390.91 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,916 | $250.41 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRIVERA FIGUEROA, MAYRA (MEDICO)